The prospective study of denosumab for the treatment of osteoporosis in hemodialysis patients
Not Applicable
- Conditions
- Osteoporosis
- Registration Number
- JPRN-UMIN000022179
- Lead Sponsor
- Yujinkai Medical Corporation Yujin-yamazaki Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
Not provided
Exclusion Criteria
Patient who have the contraindication for denosumab
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in bone mineral density(BMD) at distal radius,P1NP and TRACP-5b
- Secondary Outcome Measures
Name Time Method Change in Ca,iP,intact-PTH and side effect